Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 983 to 1032 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
983\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 3 (vamp-3) (synaptobrevin 3) (cellubrevin) (ceb). [source:swissprot;acc:q15836]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6654.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7296.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09649\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
984\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2b (transmembrane protein bri) [contains: abri/adan amyloid peptide]. [source:swissprot;acc:q9y287]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6362.64\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6976.1\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09642\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
985\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2c (transmembrane protein bri3) (npd018). [source:swissprot;acc:q9nqx7]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
986\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2a (e25 protein). [source:swissprot;acc:o43736]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
987\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
maguk p55 subfamily member 3 (mpp3 protein) (discs, large homolog 3). [source:swissprot;acc:q13368]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6660.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7301.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09636\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
988\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 n (ec 6.3.2.19) (ubiquitin-protein ligase n) (ubiquitin carrier protein n) (ubc13) (bendless-like ubiquitin conjugating enzyme). [source:swissprot;acc:q16781]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6229.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6829.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0963\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
989\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
signal transducing adaptor molecule 2; stam-like protein containing sh3 and itam domains 2. [source:refseq;acc:nm\_005843]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11743.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10712.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09624\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
990\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead-box protein 4 (vasa homolog). [source:swissprot;acc:q9nqi0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5147.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5641.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09584\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
991\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transformer-2 protein homolog (tra-2 alpha). [source:swissprot;acc:q13595]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6472.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7092.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09583\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
992\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative sialoglycoprotease type 2. [source:refseq;acc:nm\_022353]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5393.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5909.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09569\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
993\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arginine/serine-rich splicing factor 10 (transformer-2-beta) (htra2- beta) (transformer 2 protein homolog) (silica-induced protein 41) (ra301). [source:swissprot;acc:q15815]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6499.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7121.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09568\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
994\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
interleukin-4 induced protein 1 precursor (fig-1 protein). [source:swissprot;acc:q96rq9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5800.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6355.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09563\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
995\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
annexin a11 (annexin xi) (calcyclin-associated annexin 50) (cap-50) (56 kda autoantigen). [source:swissprot;acc:p50995]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5778.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6328.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09516\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
996\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
methionyl-trna formyltransferase, mitochondrial precursor (ec 2.1.2.9) (mtfmt). [source:swissprot;acc:q96dp5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5110.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5596.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09512\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
997\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein family a, member 2; component of the h/aca snornp. [source:refseq;acc:nm\_017838]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5144.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5634\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0951\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
998\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor iif, alpha subunit (tfiif-alpha) (transcription initiation factor rap74). [source:swissprot;acc:p35269]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
999\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
triacylglycerol lipase, gastric precursor (ec 3.1.1.3) (gastric lipase) (gl). [source:swissprot;acc:p07098]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5680.76\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6220.45\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.095\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1000\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba304i5.1 (novel lipase) (fragment). [source:sptrembl;acc:q96lg2]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1001\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysosomal acid lipase/cholesteryl ester hydrolase precursor (ec 3.1.1.13) (lal) (acid cholesteryl ester hydrolase) (sterol esterase) (lipase a) (cholesteryl esterase). [source:swissprot;acc:p38571]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1002\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
seryl-trna synthetase, mitochondrial precursor (ec 6.1.1.11) (serine--trna ligase) (serrsmt). [source:swissprot;acc:q9np81]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1003\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
seryl-trna synthetase (ec 6.1.1.11) (serine--trna ligase) (serrs). [source:swissprot;acc:p49591]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1004\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
o-sialoglycoprotein endopeptidase. [source:refseq;acc:nm\_017807]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5391.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5903.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09498\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1005\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
annexin a7 (annexin vii) (synexin). [source:swissprot;acc:p20073]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5780.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6329.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09497\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1006\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peripheral plasma membrane protein cask (ec 2.7.1.-) (hcask) (calcium/calmodulin-dependent serine protein kinase) (lin-2 homolog). [source:swissprot;acc:o14936]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5707.73\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6249.1\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09485\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1007\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hypoxia-inducible factor-3 alpha isoform a; inhibitory pas domain protein. [source:refseq;acc:nm\_152794]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1008\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
single-minded homolog 1. [source:swissprot;acc:p81133]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1009\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
synapsin iii. [source:swissprot;acc:o14994]\vspace{3pt}}&\multirow{13}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}}&\multirow{13}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}}&\multirow{13}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0948\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1010\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aspartate beta-hydroxylase isoform b; junctin isoform 1; junctate; aspartyl/asparaginyl-beta-hydroxylase; peptide-aspartate beta-dioxygenase; humbug. [source:refseq;acc:nm\_032468]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1011\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif 1 (hairy and enhancer of split related-1) (hesr-1) (cardiovascular helix-loop-helix factor 2) (hes-related repressor protein 2 herp2). [source:swissprot;acc:q9y5j3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1012\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin binding lim protein 2. [source:refseq;acc:nm\_032432]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1013\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif-like. [source:refseq;acc:nm\_014571]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1014\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
synapsin ii. [source:swissprot;acc:q92777]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1015\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosome recycling factor. [source:refseq;acc:nm\_138777]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1016\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal targeting signal 1 receptor (peroxismore receptor 1) (peroxisomal c-terminal targeting signal import receptor) (pts1-bp) (peroxin-5) (pts1 receptor). [source:swissprot;acc:p50542]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1017\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif 2; gridlock; hes-related repressor protein 1. [source:refseq;acc:nm\_012259]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1018\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor hes-1 (hairy and enhancer of split 1) (hairy- like) (hhl) (hairy homolog). [source:swissprot;acc:q14469]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1019\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
delta3,5-delta2,4-dienoyl-coa isomerase, mitochondrial precursor (ec 5.3.3.-). [source:swissprot;acc:q13011]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1020\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin-binding lim protein 1 isoform a; lim actin-binding protein 1; limatin; actin-binding lim protein. [source:refseq;acc:nm\_002313]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1021\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
synapsin i (brain protein 4.1). [source:swissprot;acc:p17600]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1022\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase clk2 (ec 2.7.1.-) (cdc-like kinase 2). [source:swissprot;acc:p49760]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6435.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7045.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09475\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1023\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase clk3 (ec 2.7.1.-) (cdc-like kinase 3). [source:swissprot;acc:p49761]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6435.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7044.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09474\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1024\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine-rich protein 1 (cysteine-rich intestinal protein) (crip) (cysteine-rich heart protein) (hcrhp). [source:swissprot;acc:p50238]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5706.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6245.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09446\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1025\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphomannomutase 2 (ec 5.4.2.8) (pmm 2). [source:swissprot;acc:o15305]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5511.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6031.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09434\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1026\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphomannomutase 1 (ec 5.4.2.8) (pmm 1) (pmmh-22). [source:swissprot;acc:q92871]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5509.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6029.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09427\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1027\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
s-adenosylmethionine synthetase gamma form (ec 2.5.1.6) (methionine adenosyltransferase) (adomet synthetase) (mat-ii). [source:swissprot;acc:p31153]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6123.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6700.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09422\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1028\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nicotinate-nucleotide pyrophosphorylase [carboxylating] (ec 2.4.2.19) (quinolinate phosphoribosyltransferase [decarboxylating]) (qaprtase) (qprtase). [source:swissprot;acc:q15274]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5704\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6241.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09421\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1029\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-catenin (pro2286). [source:swissprot;acc:p35222]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5635.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6166.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0942\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1030\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase i, epsilon isoform (ec 2.7.1.-) (cki-epsilon) (ckie). [source:swissprot;acc:p49674]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5048.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5523.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09419\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1031\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
membrane protein expressed in epithelial-like lung adenocarcinoma. [source:refseq;acc:nm\_024792]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6136.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6714.98\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09418\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1032\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ran binding protein 11. [source:refseq;acc:nm\_016338]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6138.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6717.05\vspace{3pt}}&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/